Upregulation of ZMAT3 is Associated with the Poor Prognosis of Breast Cancer
Our findings suggest that <i>ZMAT3</i> is a prognostic biomarker linked to immune invasion in breast cancer. Elevated <i>ZMAT3</i> expression correlates with adverse clinical outcomes, indicating its potential role in disease progression.
Authors
- Meng Wu (ORCID: https://orcid.org/0000-0002-4638-6880)
- Shuang Wu (ORCID: https://orcid.org/0009-0006-3437-8740)
- Rui Guo
Institutions
- First Hospital of China Medical University (CN)
- China Medical University (CN)
Publication Details
- Journal
- International Journal of General Medicine
- Published
- 2024-09-01
- DOI
- https://doi.org/10.2147/ijgm.s470303
- Primary Topic
- Epigenetics and DNA Methylation
- Type
- article
- Field-Weighted Citation Impact
- 0.00